Report Detail

Request for Sample of this report

Pharma & Healthcare Global Radiopharmaceutical Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2938782
    • |
  • 10 January, 2020
    • |
  • Global
    • |
  • 137 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Summary

Market Overview
The global Radiopharmaceutical market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.2% in the forecast period of 2020 to 2025 and will expected to reach USD 8281 million by 2025, from USD 6035.2 million in 2019.
The Radiopharmaceutical market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Radiopharmaceutical market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Radiopharmaceutical market has been segmented into Actinium-225, Lutetium-177, Radium-223, Holmium-166, Other, etc.
By Application, Radiopharmaceutical has been segmented into Oncology, Cardiology, Other, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Radiopharmaceutical market presented in the report. This section sheds light on the sales growth of different regional and country-level Radiopharmaceutical markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Radiopharmaceutical market.
The report offers in-depth assessment of the growth and other aspects of the Radiopharmaceutical market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Radiopharmaceutical markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Radiopharmaceutical Market Share Analysis
Radiopharmaceutical competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Radiopharmaceutical sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Radiopharmaceutical sales, revenue and market share for each player covered in this report.
The major players covered in Radiopharmaceutical are: Bracco Imaging, GE Healthcare, Nordion, Bayer, IBA Group, Mallinckrodt, Jubilant Pharma, Lantheus, Triad Isotopes, China Isotope & Radiation, Navidea, Eli Lilly, Dongcheng, Advanced Accelerator Applications, SIEMENS, etc. Among other players domestic and global, Radiopharmaceutical market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceutical product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Radiopharmaceutical, with price, sales, revenue and global market share of Radiopharmaceutical in 2018 and 2019.
Chapter 3, the Radiopharmaceutical competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceutical breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Radiopharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Radiopharmaceutical sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Radiopharmaceutical Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Overview: Global Radiopharmaceutical Revenue by Type: 2015 VS 2019 VS 2025
      • 1.2.2 Actinium-225
      • 1.2.3 Lutetium-177
      • 1.2.4 Radium-223
      • 1.2.5 Holmium-166
      • 1.2.6 Other
    • 1.3 Market Analysis by Application
      • 1.3.1 Overview: Global Radiopharmaceutical Revenue by Application: 2015 VS 2019 VS 2025
      • 1.3.2 Oncology
      • 1.3.3 Cardiology
      • 1.3.4 Other
    • 1.4 Overview of Global Radiopharmaceutical Market
      • 1.4.1 Global Radiopharmaceutical Market Status and Outlook (2015-2025)
      • 1.4.2 North America (United States, Canada and Mexico)
      • 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
      • 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      • 1.4.5 South America, Middle East & Africa
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Bracco Imaging
      • 2.1.1 Bracco Imaging Details
      • 2.1.2 Bracco Imaging Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.1.3 Bracco Imaging SWOT Analysis
      • 2.1.4 Bracco Imaging Product and Services
      • 2.1.5 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.2 GE Healthcare
      • 2.2.1 GE Healthcare Details
      • 2.2.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.2.3 GE Healthcare SWOT Analysis
      • 2.2.4 GE Healthcare Product and Services
      • 2.2.5 GE Healthcare Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.3 Nordion
      • 2.3.1 Nordion Details
      • 2.3.2 Nordion Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.3.3 Nordion SWOT Analysis
      • 2.3.4 Nordion Product and Services
      • 2.3.5 Nordion Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.4 Bayer
      • 2.4.1 Bayer Details
      • 2.4.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.4.3 Bayer SWOT Analysis
      • 2.4.4 Bayer Product and Services
      • 2.4.5 Bayer Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.5 IBA Group
      • 2.5.1 IBA Group Details
      • 2.5.2 IBA Group Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.5.3 IBA Group SWOT Analysis
      • 2.5.4 IBA Group Product and Services
      • 2.5.5 IBA Group Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.6 Mallinckrodt
      • 2.6.1 Mallinckrodt Details
      • 2.6.2 Mallinckrodt Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.6.3 Mallinckrodt SWOT Analysis
      • 2.6.4 Mallinckrodt Product and Services
      • 2.6.5 Mallinckrodt Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.7 Jubilant Pharma
      • 2.7.1 Jubilant Pharma Details
      • 2.7.2 Jubilant Pharma Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.7.3 Jubilant Pharma SWOT Analysis
      • 2.7.4 Jubilant Pharma Product and Services
      • 2.7.5 Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.8 Lantheus
      • 2.8.1 Lantheus Details
      • 2.8.2 Lantheus Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.8.3 Lantheus SWOT Analysis
      • 2.8.4 Lantheus Product and Services
      • 2.8.5 Lantheus Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.9 Triad Isotopes
      • 2.9.1 Triad Isotopes Details
      • 2.9.2 Triad Isotopes Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.9.3 Triad Isotopes SWOT Analysis
      • 2.9.4 Triad Isotopes Product and Services
      • 2.9.5 Triad Isotopes Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.10 China Isotope & Radiation
      • 2.10.1 China Isotope & Radiation Details
      • 2.10.2 China Isotope & Radiation Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.10.3 China Isotope & Radiation SWOT Analysis
      • 2.10.4 China Isotope & Radiation Product and Services
      • 2.10.5 China Isotope & Radiation Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.11 Navidea
      • 2.11.1 Navidea Details
      • 2.11.2 Navidea Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.11.3 Navidea SWOT Analysis
      • 2.11.4 Navidea Product and Services
      • 2.11.5 Navidea Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.12 Eli Lilly
      • 2.12.1 Eli Lilly Details
      • 2.12.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.12.3 Eli Lilly SWOT Analysis
      • 2.12.4 Eli Lilly Product and Services
      • 2.12.5 Eli Lilly Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.13 Dongcheng
      • 2.13.1 Dongcheng Details
      • 2.13.2 Dongcheng Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.13.3 Dongcheng SWOT Analysis
      • 2.13.4 Dongcheng Product and Services
      • 2.13.5 Dongcheng Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.14 Advanced Accelerator Applications
      • 2.14.1 Advanced Accelerator Applications Details
      • 2.14.2 Advanced Accelerator Applications Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.14.3 Advanced Accelerator Applications SWOT Analysis
      • 2.14.4 Advanced Accelerator Applications Product and Services
      • 2.14.5 Advanced Accelerator Applications Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.15 SIEMENS
      • 2.15.1 SIEMENS Details
      • 2.15.2 SIEMENS Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.15.3 SIEMENS SWOT Analysis
      • 2.15.4 SIEMENS Product and Services
      • 2.15.5 SIEMENS Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

    3 Sales, Revenue and Market Share by Manufacturer

    • 3.1 Global Radiopharmaceutical Sales and Market Share by Manufacturer (2018-2019)
    • 3.2 Global Radiopharmaceutical Revenue and Market Share by Manufacturer (2018-2019)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Radiopharmaceutical Manufacturer Market Share in 2019
      • 3.3.2 Top 6 Radiopharmaceutical Manufacturer Market Share in 2019
    • 3.4 Market Competition Trend

    4 Global Market Analysis by Regions

    • 4.1 Global Radiopharmaceutical Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Radiopharmaceutical Sales and Market Share by Regions (2015-2020)
      • 4.1.2 Global Radiopharmaceutical Revenue and Market Share by Regions (2015-2020)
    • 4.2 North America Radiopharmaceutical Sales and Growth Rate (2015-2020)
    • 4.3 Europe Radiopharmaceutical Sales and Growth Rate (2015-2020)
    • 4.4 Asia-Pacific Radiopharmaceutical Sales and Growth Rate (2015-2020)
    • 4.5 South America Radiopharmaceutical Sales and Growth Rate (2015-2020)
    • 4.6 Middle East and Africa Radiopharmaceutical Sales and Growth Rate (2015-2020)

    5 North America by Country

    • 5.1 North America Radiopharmaceutical Sales, Revenue and Market Share by Country
      • 5.1.1 North America Radiopharmaceutical Sales and Market Share by Country (2015-2020)
      • 5.1.2 North America Radiopharmaceutical Revenue and Market Share by Country (2015-2020)
    • 5.2 United States Radiopharmaceutical Sales and Growth Rate (2015-2020)
    • 5.3 Canada Radiopharmaceutical Sales and Growth Rate (2015-2020)
    • 5.4 Mexico Radiopharmaceutical Sales and Growth Rate (2015-2020)

    6 Europe by Country

    • 6.1 Europe Radiopharmaceutical Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Radiopharmaceutical Sales and Market Share by Country (2015-2020)
      • 6.1.2 Europe Radiopharmaceutical Revenue and Market Share by Country (2015-2020)
    • 6.2 Germany Radiopharmaceutical Sales and Growth Rate (2015-2020)
    • 6.3 UK Radiopharmaceutical Sales and Growth Rate (2015-2020)
    • 6.4 France Radiopharmaceutical Sales and Growth Rate (2015-2020)
    • 6.5 Russia Radiopharmaceutical Sales and Growth Rate (2015-2020)
    • 6.6 Italy Radiopharmaceutical Sales and Growth Rate (2015-2020)

    7 Asia-Pacific by Regions

    • 7.1 Asia-Pacific Radiopharmaceutical Sales, Revenue and Market Share by Regions
      • 7.1.1 Asia-Pacific Radiopharmaceutical Sales and Market Share by Regions (2015-2020)
      • 7.1.2 Asia-Pacific Radiopharmaceutical Revenue and Market Share by Regions (2015-2020)
    • 7.2 China Radiopharmaceutical Sales and Growth Rate (2015-2020)
    • 7.3 Japan Radiopharmaceutical Sales and Growth Rate (2015-2020)
    • 7.4 Korea Radiopharmaceutical Sales and Growth Rate (2015-2020)
    • 7.5 India Radiopharmaceutical Sales and Growth Rate (2015-2020)
    • 7.6 Southeast Asia Radiopharmaceutical Sales and Growth Rate (2015-2020)
    • 7.7 Australia Radiopharmaceutical Sales and Growth Rate (2015-2020)

    8 South America by Country

    • 8.1 South America Radiopharmaceutical Sales, Revenue and Market Share by Country
      • 8.1.1 South America Radiopharmaceutical Sales and Market Share by Country (2015-2020)
      • 8.1.2 South America Radiopharmaceutical Revenue and Market Share by Country (2015-2020)
    • 8.2 Brazil Radiopharmaceutical Sales and Growth Rate (2015-2020)
    • 8.3 Argentina Radiopharmaceutical Sales and Growth Rate (2015-2020)

    9 Middle East & Africa by Countries

    • 9.1 Middle East & Africa Radiopharmaceutical Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East & Africa Radiopharmaceutical Sales and Market Share by Country (2015-2020)
      • 9.1.2 Middle East & Africa Radiopharmaceutical Revenue and Market Share by Country (2015-2020)
    • 9.2 Saudi Arabia Radiopharmaceutical Sales and Growth Rate (2015-2020)
    • 9.3 Turkey Radiopharmaceutical Sales and Growth Rate (2015-2020)
    • 9.4 Egypt Radiopharmaceutical Sales and Growth Rate (2015-2020)
    • 9.5 South Africa Radiopharmaceutical Sales and Growth Rate (2015-2020)

    10 Market Segment by Type

    • 10.1 Global Radiopharmaceutical Sales and Market Share by Type (2015-2020)
    • 10.2 Global Radiopharmaceutical Revenue and Market Share by Type (2015-2020)
    • 10.3 Global Radiopharmaceutical Price by Type (2015-2020)

    11 Global Radiopharmaceutical Market Segment by Application

    • 11.1 Global Radiopharmaceutical Sales Market Share by Application (2015-2020)
    • 11.2 Global Radiopharmaceutical Revenue Market Share by Application (2015-2020)
    • 11.3 Global Radiopharmaceutical Price by Application (2015-2020)

    12 Market Forecast

    • 12.1 Global Radiopharmaceutical Sales, Revenue and Growth Rate (2021-2025)
    • 12.2 Radiopharmaceutical Market Forecast by Regions (2021-2025)
      • 12.2.1 North America Radiopharmaceutical Market Forecast (2021-2025)
      • 12.2.2 Europe Radiopharmaceutical Market Forecast (2021-2025)
      • 12.2.3 Asia-Pacific Radiopharmaceutical Market Forecast (2021-2025)
      • 12.2.4 South America Radiopharmaceutical Market Forecast (2021-2025)
      • 12.2.5 Middle East & Africa Radiopharmaceutical Market Forecast (2021-2025)
    • 12.3 Radiopharmaceutical Market Forecast by Type (2021-2025)
      • 12.3.1 Global Radiopharmaceutical Sales Forecast by Type (2021-2025)
      • 12.3.2 Global Radiopharmaceutical Market Share Forecast by Type (2021-2025)
    • 12.4 Radiopharmaceutical Market Forecast by Application (2021-2025)
      • 12.4.1 Global Radiopharmaceutical Sales Forecast by Application (2021-2025)
      • 12.4.2 Global Radiopharmaceutical Market Share Forecast by Application (2021-2025)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology
      • 15.2 Data Source
      • 15.3 Disclaimer

      Summary:
      Get latest Market Research Reports on Radiopharmaceutical . Industry analysis & Market Report on Radiopharmaceutical is a syndicated market report, published as Global Radiopharmaceutical Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Radiopharmaceutical market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,724.84
      		4,087.26
      		5,449.68
      		3,205.08
      		4,807.62
      		6,410.16
      		545,907.60
      		818,861.40
      		1,091,815.20
      		289,362.00
      		434,043.00
      		578,724.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo